Graham Griffiths
Corporate Officer/Principal at BARINTHUS BIOTHERAPEUTICS PLC
Net worth: 253 124 $ as of 2024-04-29
Profile
Graham Griffiths was the founder of Agalimmune Ltd.
which was founded in 2013, where he held the title of Chief Operating Officer & Director until 2017.
Currently, he is the Chief Business Officer at Barinthus Biotherapeutics Plc since 2017.
Mr. Griffiths has previously worked as a Director at MET Parking Services Ltd.
from 2005 to 2007.
He also worked as a Fund Manager at Matrix Securities Ltd.
Mr. Griffiths is a graduate of Newcastle University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-12 | 104,209 ( 0.31% ) | 253 124 $ | 2024-04-29 |
Graham Griffiths active positions
| Companies | Position | Start |
|---|---|---|
| BARINTHUS BIOTHERAPEUTICS PLC | Corporate Officer/Principal | 2017-09-30 |
Former positions of Graham Griffiths
| Companies | Position | End |
|---|---|---|
Agalimmune Ltd.
 Agalimmune Ltd. Pharmaceuticals: MajorHealth Technology Part of BioLineRx Ltd., Agalimmune Ltd. is a British company that develops anti-cancer immunotherapy technology. The company is based in London, UK. The company was founded by Charles Campbell Roberts and Graham Griffiths. The CEO is Mike Westby. Agalimmune was acquired by BioLineRx Ltd. on March 23, 2017 for $6.05 million. | Founder | 2017-08-31 |
| MET Parking Services Ltd. | Director/Board Member | 2007-06-30 |
Matrix Securities Ltd.
 Matrix Securities Ltd. Investment ManagersFinance Matrix Securities Ltd. (MS) is the investment management and services division and a subsidiary of Matrix Group Ltd. Several specialized subsidiaries operate jointly under the Matrix Securities brand. These entities service venture capital trusts, raise capital for private equity funds managed externally, source limited partner interests, administer securitized property and design structured products as well as innovative financing vehicles for film production purposes. MS is also involved in alternative investing through their subsidiary Matrix Alternative Asset Management which manages hedge funds. MS was established in 1987 and is located in London. The firm's clients are European institutions. MS has specialist expertise in raising capital for small entrepreneurial companies. | Corporate Officer/Principal | - |
Training of Graham Griffiths
| Newcastle University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BARINTHUS BIOTHERAPEUTICS PLC | Health Technology |
| Private companies | 3 |
|---|---|
Agalimmune Ltd.
Agalimmune Ltd. Pharmaceuticals: MajorHealth Technology Part of BioLineRx Ltd., Agalimmune Ltd. is a British company that develops anti-cancer immunotherapy technology. The company is based in London, UK. The company was founded by Charles Campbell Roberts and Graham Griffiths. The CEO is Mike Westby. Agalimmune was acquired by BioLineRx Ltd. on March 23, 2017 for $6.05 million. | Health Technology |
| MET Parking Services Ltd. | |
Matrix Securities Ltd.
Matrix Securities Ltd. Investment ManagersFinance Matrix Securities Ltd. (MS) is the investment management and services division and a subsidiary of Matrix Group Ltd. Several specialized subsidiaries operate jointly under the Matrix Securities brand. These entities service venture capital trusts, raise capital for private equity funds managed externally, source limited partner interests, administer securitized property and design structured products as well as innovative financing vehicles for film production purposes. MS is also involved in alternative investing through their subsidiary Matrix Alternative Asset Management which manages hedge funds. MS was established in 1987 and is located in London. The firm's clients are European institutions. MS has specialist expertise in raising capital for small entrepreneurial companies. | Finance |
- Stock Market
- Insiders
- Graham Griffiths
